All subjects and patients, n = 68 |
CD4+ EM (% CD4+) |
Serum cholesterol |
0.24 |
P<0.05 |
All subjects and patients, n = 68 |
CD4+ EM (% CD4+) |
Serum glucose |
0.25 |
P<0.05 |
Lean normotensives n = 24 |
CD4+ EM (% CD4+) |
Serum glucose |
0.40 |
P<0.05 |
Lean hypertensives n = 12 |
CD4+ EM (% CD4+) |
Serum cholesterol |
0.62 |
P<0.05 |
Obese normotensive patients, n = 18 |
CD4+ EM (% CD4+) |
Serum triglycerides |
0.69 |
P<0.001 |
All subjects and patients, n = 68 |
Tregs (%) |
Serum triglycerides |
-0.27 |
P<0.05 |
All subjects and patients, n = 68 |
Tregs CM (% Tregs) |
Serum triglycerides |
-0.23 |
P<0.05 |
Lean hypertensives n = 24 |
Tregs (%) |
Serum cholesterol |
-0.57 |
P<0.05 |
Lean hypertensives n = 24 |
Tregs naïve (% Tregs) |
Serum cholesterol |
-0.81 |
P<0.001 |
Lean hypertensives n = 24 |
Tregs naïve (cells/μL) |
Serum cholesterol |
-0.70 |
P<0.01 |
Obese normotensive patients, n = 18 |
Tregs naïve (cells/μL) |
Serum triglycerides |
-0.56 |
P<0.01 |